GSK vs VIA · P/E 13, $103.31B cap vs rev $434.3M
GlaxoSmithKline PLC ADR (GSK) versus Via Transportation, Inc. (VIA) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Via Transportation, Inc. (VIA) is a software - application company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported VIA revenue for 2025-12-31 was $434.3M. Net income was -$96.4M. Revenue was up 28.6% from 2024-12-31 to 2025-12-31. VIA currently screens at market cap $1.26B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. VIA currently screens at market cap $1.26B.
Not investment advice. Open the GSK and VIA stock pages for the full models.
Not investment advice.